Prevalence of diabetes in patients with nonacute CAD

Kannel WB, McGee DL (1978) Diabetes and cardiovascular risk factors in the Framingham Study. JAMA 38:46–51 Stamler J, Vaccaro O, Neaton J, Wentworth D (1993) Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434–444 Rizza S, Cardellini M, Martelli E, Porzio O, Pecchioli C, Nicolucci A, Marx N, Lauro D, Ippoliti A, Romeo F, Lauro R, Federici M (2010) Occult impaired glucose regulation in patients with atherosclerosis is associated to the number of affected vascular districts and inflammation. Atherosclerosis 212(1):316–320 Haffner SM, Lehto S, Ronnemaa T, Pyörälä K, Laakso M (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234 Rizza S, Clementi F, Porzio O, Cardellini M, Savo A, Serino M, Chiricolo G, Romeo F, Lauro R, Federici M (2009) Adiponectin isoforms are not associated with the severity of coronary atherosclerosis but with undiagnosed diabetes in patients affected by stable CAD. Nutr Metab Cardiovasc Dis 19(1):54–60 Füth R, Dinh W, Bansemir L, Ziegler G, Bufe A, Wolfertz J, Scheffold T, Lankisch M (2009) Newly detected glucose disturbance is associated with a high prevalence of diastolic dysfunction: double risk for the development of heart failure? Acta Diabetol 46(4):335–338 Position statement (2009) Standards of medical care in diabetes-2009. Diabetes Care 32:S13–S61 Gaede P, Lund-Andersen H, Parving HH, Pedersen O (2008) Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 358:580–591